arrow
返回
刘红敏 封面图

刘红敏 (Hong‐Min Liu)

Zhengzhou University

44H指数
330论文数
7.1K被引数
收录论文 274
发表时间
Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological Functions加速小分子铁死亡调节剂的开发进展与生物学功能研究
err2026-02-23
err0
PREAI
errLinyue Bai; Liang Shen; Qianqian Zhang; Zhuang Hu; Yanjun Tang; Mengjie Fu; Yange Fan; Huifeng Wang; Hong-Min Liu; Xing-Jie Dai; Siqi Feng
err分享
err收藏
A Comprehensive Review of Marketed KRAS Inhibitors and Degraders: Challenges and Opportunitiesmarketed KRAS抑制剂和降解剂的全面综述:挑战与机遇
err2026-02-09
err0
PREAI
errYi-Xin Xu; Yi-Ru Bai; Ruifang Li; Yi-Ming Peng; Ting-Ting Liu; Xin Yang; Ke-Tong Chen; Zhi-Peng Jin; Hong-Min Liu; Shuo Yuan
err分享
err收藏
err分享
err收藏
Identification of Novel Phenoxazine-Derived LSD1 Inhibitors Suppressing Gastric Cancer Stemness by β-Catenin Transcriptional Regulation
err2025-10-01
err0
PREAI
errDai, Xing-Jie; Xue, Leipeng; Liu, Ying; Wang, Shu-Wu; Li, Ying; Yin, Jia-Yi; Long, Hao-Zhe; Liu, Hui-Min; Wang, Ning; Lu, Guo-Liang; Li, Yan; Liu, Hong-Min; Wang, Bo; Zheng, Yi-Chao
err分享
err收藏
The LSD1/HDAC dual-target inhibitor for cancer therapy: Challenge and opportunity癌症治疗中的LSD1/HDAC双靶点抑制剂:挑战与机遇
err2025-08-06
err0
PREAI
errDan-Dan Shen; Hao-Qian Zhang; Chen-Chen Ren; Yong-Xing Chen; Ying Xu; Rui-Fang Li; Yi-Ru Bai; Hong-Min Liu; Shuo Yuan; Li Yang
err分享
err收藏
A comprehensive review of small molecule drugs approved by the FDA in 2024: Advance and prospect2024年FDA批准的小分子药物综述:进展与展望
err2025-03-07
err0
PREAI
errYi-Ru Bai; Qing-Chuan Duan; Dong-Jie Seng; Ying Xu; Hong-Bo Ren; Jie Zhang; Dan-Dan Shen; Li Yang; Hong-Min Liu; Shuo Yuan
err分享
err收藏